BURNING ROCK BIOTECH
Burning Rock focuses on providing individualized cancer treatment guidance for the patients. Using medical and bio informatics plus Next-Generation Sequencing (NGS) as the core technologies, the company is committed to offering one-stop solution for clinical and R&D services concerning the genetic testing of individualized cancer treatment. Established in March 2014, Burning Rock is headquartered in Beijing. Its first medical laboratory, "Guangzhou Burning Rock Medical Examination Institute Co.... , Ltd." is situated on Guangzhou International Bio Island which is blessed with a picturesque environment and rich in scientific research deposits. Later it established a R&D center in Shanghai. It occupies over 10,000 ㎡ in total. Burning Rock is committed to guiding the individualistic treatment of tumor patients, centered around NGS and biomedical informatics, with conventional tumor molecular pathology detection as the cornerstone, trying to build one-stop solutions for individualistic treatment clinical detection service and scientific research of tumor.
BURNING ROCK BIOTECH
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2014-03-01
Address:
Guangzhou, Guangdong, China
Country:
China
Website Url:
http://www.brbiotech.com
Total Employee:
501+
Status:
Active
Contact:
020-34037872
Email Addresses:
[email protected]
Total Funding:
193.16 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
CollabRx
CollabRx uses information technology to provide personalized cancer treatment planning services to cancer patients.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
ARK Investment Management
ARK Investment Management investment in Post-IPO Equity - Burning Rock Biotech
GIC
GIC investment in Series C - Burning Rock Biotech
CMB International Capital Corporation
CMB International Capital Corporation investment in Series C - Burning Rock Biotech
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - Burning Rock Biotech
Sequoia Capital China
Sequoia Capital China investment in Series C - Burning Rock Biotech
LYFE Capital
LYFE Capital investment in Series C - Burning Rock Biotech
Taihe Capital
Taihe Capital investment in Series C - Burning Rock Biotech
Sequoia Capital China
Sequoia Capital China investment in Series B - Burning Rock Biotech
CMB International Capital Corporation
CMB International Capital Corporation investment in Series B - Burning Rock Biotech
LYFE Capital
LYFE Capital investment in Series B - Burning Rock Biotech
Official Site Inspections
http://www.brbiotech.com Semrush global rank: 7.12 M Semrush visits lastest month: 585
- Host name: 112.74.111.27
- IP address: 112.74.111.27
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Burning Rock Biotech"
Burning Rock Biotech - Crunchbase Company Profile & Funding
Organization. Burning Rock Biotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email …See details»
Burning Rock , Burning Rock Dx
Burning Rock Dx (NASDAQ: BNR) is a global diagnostics company focusing on applying next-generation sequencing (NGS) technology in precision oncology.See details»
Burning Rock Dx | LinkedIn
Burning Rock Dx is pleased to announce its participation in the 9th Liquid Biopsy for Precision Oncology Summit, taking place in San Diego from February 18-20, 2025.See details»
Management - Burning Rock Biotech Limited
Dr. Zhihong (Joe) Zhang has served as our director since June 2023. Dr.Zhang joined us as chief technology officer in March 2016. Prior to joining us, Dr. Zhang was a staff scientist of Illumina, …See details»
燃石医学 - 红杉中国 - HongShan
燃石医学（纳斯达克代码：bnr）成立于2014年，公司使命为“用科学守护生命之光”，专注于开发创新可靠、具有临床价值的癌症伴随诊断与早检产品。See details»
Burning Rock and IMPACT Therapeutics Announce a Global …
For more information about Burning Rock, please visit: ir.brbiotech.com. Safe Harbor Statement This press release contains forward-looking statements. These statements constitute “forward …See details»
China: No.5, Xingdao Huanbei Road, International Bio Island, …
Dr. Zhihong (Joe) Zhang serves as our Chief Technology Officer since March 2016. Prior to joining us, Dr. Zhang was a Staff Scientist of Illumina, Inc., and a senior fellow of Howard …See details»
Biopharma Partner Services - BRBIOTECH
Email: [email protected] Tel: +8621-6029-3725. 2015-2018 燃石医学权所有粤ICP备 14067392 号 the service items involved in this material do not involve the disclosure and sharing of personal information without patients' informed …See details»
us.brbiotech.com
US: 121 Innovation Drive Suite 100, Irvine CA, 92617. China: No.5, Xingdao Huanbei Road, International Bio Island, Guangzhou, Guangdong China 510300See details»
Burning Rock Biotech Limited Announces Expected Delisting of …
GUANGZHOU, China, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (the “Company” or “Burning Rock”) announces that, on August 19, 2024, it intends to submit …See details»
Burning Rock Biotech - Overview, News & Similar companies
Mar 29, 2024 www.brbiotech.com. Revenue $78.3 Million. Stock Symbol BNR. Industry Medical Testing & Clinical Laboratories Healthcare . Recent News & Media. Burning Rock Reports …See details»
肿瘤基因检测_药企合作_多癌种早检_癌症 ... - BRBIOTECH
燃石医学是一家专注于肿瘤基因检测和癌症早期筛查的药企，与医疗机构合作，推广多癌种早检服务。我们的基因检测可精确诊断癌症类型和分级，提供个体化治疗方案。基于血液的早期筛查 …See details»
Third Quarter 2024 Financial Results - brbiotech.gcs-web.com
Contact: [email protected]. 4 Selected Operating Data As of September 30, 2023 December 31, 2023 March 31, 2024 June 30, 2024 September 30, 2024 In-hospital Channel: Pipeline …See details»
拜耳和Burning Rock合作增加患者获得癌症精准药物的机会
May 30, 2024 “We are delighted to have established a companion diagnostics collaboration with Bayer, a global leader in the biopharmaceutical industry. Burning Rock is committed to the …See details»
Burning Rock Received FDA Breakthrough Device Designation for …
IRVINE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Burning Rock (NASDAQ/LSE: BNR), a company focused on the application of next generation sequencing (NGS) technology in the …See details»
肿瘤基因检测_药企合作_多癌种早检_癌症 ... - BRBIOTECH
For more information about Burning Rock, please visit: ir.brbiotech.com. Safe Harbor Statement. This press release contains forward-looking statements. These statements constitute “forward …See details»
How the Biotechnology Industry Works | Umbrex
Biotechnology companies ultimately serve a variety of customers and end-users across multiple sectors. The major customer segments include: Healthcare Providers and Patients: For …See details»
us.brbiotech.com
For more information about Burning Rock, please visit: https://us.brbiotech.com. Learn More August 21, 2024. Bayer and Burning Rock collaborate to increase patient access to precision …See details»
Genomic Data Solutions - us.brbiotech.com
750K+ Tests Performed. Local Samples, Real-time Tracking Multi-dimensional Data Solutions Throughout the Life-cycle of Drug DevelopmentSee details»
us.brbiotech.com
Actively prospect and leverage potential new business opportunities within specified potential new and/or existing customers in US market; Develop business and regulatory plan for US market, …See details»